These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 22122915)

  • 1. Low dose hypericin-PDT induces complete tumor regression in BALB/c mice bearing CT26 colon carcinoma.
    Sanovic R; Verwanger T; Hartl A; Krammer B
    Photodiagnosis Photodyn Ther; 2011 Dec; 8(4):291-6. PubMed ID: 22122915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy can be enhanced by the use of a low dose of photofrin in human tumor xenografts.
    Peng Q; Warloe T; Moan J; Godal A; Apricena F; Giercksky KE; Nesland JM
    Cancer Res; 2001 Aug; 61(15):5824-32. PubMed ID: 11479222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of hypericin-mediated photodynamic therapy on the expression of vascular endothelial growth factor in human nasopharyngeal carcinoma.
    Bhuvaneswari R; Gan YY; Yee KK; Soo KC; Olivo M
    Int J Mol Med; 2007 Oct; 20(4):421-8. PubMed ID: 17786271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo photodynamic activity of hypericin in transitional cell carcinoma bladder tumors.
    Zupkó I; Kamuhabwa AR; D'Hallewin MA; Baert L; De Witte PA
    Int J Oncol; 2001 May; 18(5):1099-105. PubMed ID: 11295062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biodistribution and photodynamic therapy with hypericin in a human NPC murine tumor model.
    Du HY; Bay BH; Olivo M
    Int J Oncol; 2003 May; 22(5):1019-24. PubMed ID: 12684667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypericin-photodynamic therapy (PDT) using an alternative treatment regime suitable for multi-fraction PDT.
    Thong PS; Watt F; Ren MQ; Tan PH; Soo KC; Olivo M
    J Photochem Photobiol B; 2006 Jan; 82(1):1-8. PubMed ID: 16203156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancing the therapeutic responsiveness of photodynamic therapy with the antiangiogenic agents SU5416 and SU6668 in murine nasopharyngeal carcinoma models.
    Zhou Q; Olivo M; Lye KY; Moore S; Sharma A; Chowbay B
    Cancer Chemother Pharmacol; 2005 Dec; 56(6):569-77. PubMed ID: 16001166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Photodynamic therapy with hypericin in a mouse P388 tumor model: vascular effects determine the efficacy.
    Chen B; Zupkó I; de Witte PA
    Int J Oncol; 2001 Apr; 18(4):737-42. PubMed ID: 11251168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of hexamethylhypericin and tetrabromohypericin to hypericin for their in vivo efficacy as PDT tools.
    Delaey E; Zupko I; Chen B; Derycke A; van Laar F; De Vos D; De Witte P
    Int J Oncol; 2003 Aug; 23(2):519-24. PubMed ID: 12851704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypericin-mediated photodynamic therapy induces lipid peroxidation and necrosis in nasopharyngeal cancer.
    Du HY; Olivo M; Tan BK; Bay BH
    Int J Oncol; 2003 Nov; 23(5):1401-5. PubMed ID: 14532982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Photosensitizing activity of hypericin and hypericin acetate after topical application on normal mouse skin.
    Boiy A; Roelandts R; van den Oord J; de Witte PA
    Br J Dermatol; 2008 Feb; 158(2):360-9. PubMed ID: 18047507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Photosensitizer nanoparticles photodynamic therapy on LOVO human colon cancer xenografts in athymic mice].
    Qing SH; Li LY; Sheng XH; Ba MC
    Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Nov; 9(6):530-3. PubMed ID: 17143803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of antitumoral photodynamic therapy with hypericin: relationship between biodistribution and photodynamic effects in the RIF-1 mouse tumor model.
    Chen B; Xu Y; Roskams T; Delaey E; Agostinis P; Vandenheede JR; de Witte P
    Int J Cancer; 2001 Jul; 93(2):275-82. PubMed ID: 11410877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancing the photodynamic effect of hypericin in human bladder transitional cell carcinoma spheroids by the use of the oxygen carrier, perfluorodecalin.
    Kamuhabwa AR; Huygens A; Roskams T; De Witte PA
    Int J Oncol; 2006 Mar; 28(3):775-80. PubMed ID: 16465384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypericin activated by an incoherent light source has photodynamic effects on esophageal cancer cells.
    Höpfner M; Maaser K; Theiss A; Lenz M; Sutter AP; Kashtan H; von Lampe B; Riecken EO; Zeitz M; Scherübl H
    Int J Colorectal Dis; 2003 May; 18(3):239-47. PubMed ID: 12673490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photoinduced antitumour effect of hypericin can be enhanced by fractionated dosing.
    Cavarga I; Brezáni P; Fedorocko P; Miskovský P; Bobrov N; Longauer F; Rybárova S; Mirossay L; Stubna J
    Phytomedicine; 2005 Sep; 12(9):680-3. PubMed ID: 16194057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment with the tumor necrosis factor-alpha-inducing drug 5,6-dimethylxanthenone-4-acetic acid enhances the antitumor activity of the photodynamic therapy of RIF-1 mouse tumors.
    Bellnier DA; Gollnick SO; Camacho SH; Greco WR; Cheney RT
    Cancer Res; 2003 Nov; 63(22):7584-90. PubMed ID: 14633671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bio-distribution and subcellular localization of Hypericin and its role in PDT induced apoptosis in cancer cells.
    Ali SM; Olivo M
    Int J Oncol; 2002 Sep; 21(3):531-40. PubMed ID: 12168096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor vascular response to photodynamic therapy and the antivascular agent 5,6-dimethylxanthenone-4-acetic acid: implications for combination therapy.
    Seshadri M; Spernyak JA; Mazurchuk R; Camacho SH; Oseroff AR; Cheney RT; Bellnier DA
    Clin Cancer Res; 2005 Jun; 11(11):4241-50. PubMed ID: 15930363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photodynamic therapy of transitional cell carcinoma multicellular tumor spheroids with hypericin.
    Kamuhabwa AA; Huygens A; De Witte PA
    Int J Oncol; 2003 Nov; 23(5):1445-50. PubMed ID: 14532989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.